Noradrenergic and serotonergic abnormalities in depression: Stress-induced dysfunction?

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 4, 1996, Pages 14-18

  Dinan, Timothy G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NORADRENERGIC NERVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC NERVE; STRESS;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; DEPRESSIVE DISORDER; GROWTH HORMONE; HUMANS; HYDROCORTISONE; LIFE CHANGE EVENTS; MIANSERIN; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; RECEPTORS, GLUCOCORTICOID; RECEPTORS, SEROTONIN; SEROTONIN; STRESS; STRESS, PSYCHOLOGICAL;

EID: 0029937367     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science 1967; 156:21-30
2. Mann JJ, Stanley M, McBride A, et al. Increased serotonin-2 and β adrenergic receptor binding in the frontal cortices of suicidal victims. Arch Gen Psychiatry 1986;43:954-959
3. Trimble MR. Biological Psychiatry, New York, NY: John Wiley & Sons; 1988:241-283
4. Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system, I: demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964;62(suppl 232):1-55
5. Redmond DE, Huang YH. Current concepts, II: new evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 1979;25: 2149-2162
6. Iversen LL. The Uptake and Storage of Noradrenaline in Sympathetic Nerves. London, England: Cambridge University Press; 1991
7. Charney DS, Redmond DE. Neurological mechanisms in human anxiety: evidence supporting central noradrenergic hyperactivity. Neuropharmacology 1983;22:1531-1536
8. Ross RJ, Tsagarkis S, Grossman A, et al. GH feedback occurs through the modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clin Endocrinol (Oxf) 1987;27: 727-733
9. Katakami H, Kato Y, Matsushita N, et al. Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E1 in conscious male rats. Neuroendocrinology 1984; 38:1-5
10. Checkley SA, Slade AP, Shur P. Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 1981; 138:51-55
11. Barry S, Dinan TG. The effect of antidepressant treatment on α-2 adrenoceptor function in DSM-III major depression. Ir J Psychol Med 1989;6:109-111
12. Checkley SA, Corn TH, Glass IB, et al. The responsiveness of central α-2 adrenoceptors in depression. In: Deakin JFW, ed. The Biology of Depression. London, England: Gaskell Press; 1986:110-134
13. Dinan TG, Ahkion S, Chua A, et al. Assessment of central noradrenergic functioning in irritable bowel syndrome, using a neuroendocrine challenge test. J Psychosom Res 1990;34:575-588
14. Charney DS, Heninger GR. Abnormal regulation of noradrenergic function in panic disorders: effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1986;43:1042-1054
15. Baumgarten HG, Grozdanovic Z. Neuroanatomy and neurophysiology of central serotonergic systems. J Serotonin Res 1994;3:171-179
16. Jacobs BL, Wilkinson LO, Fornal CA. The role of brain serotonin, a neurophysiologic perspective. Neuropsychopharmacology 1990;3:473-479
17. Fuller RW. Pharmacology of central serotonin neurones. Ann Rev Pharmacol 1980;20:111-127
18. Gaddum JH, Picarelli ZP. Two kinds of tryptamine receptor. J Pharmacol Chemotherapy 1957;12:323-328
19. Humphrey PPA, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993;14:233-237
20. 7 serotonin receptors: molecular biology and pharmacology. Neurotransmissions 1995;11: 1-5
21. Dinan TG. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci. In press
22. 1A receptor responsivity in unipolar depression: evaluation of ipsapirone induced ACTH and cortisol secretion in depressed patients. Biol Psychiatry 1990; 28:620-628
23. 1A receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci 1990;46:1271-1277
24. Lamberts SWJ, MacLeod RM. Regulation of prolactin release at the level of the lactotrope. Physiol Rev 1990;70:279-318
25. 1 serotonin receptors in the medical basal hypothalamus stimulates prolactin secretion in the unanesthetized rat. Neuroendocrinology 1988;47:83-87
26. Cowen PJ, Charig EM. Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry 1987;44:958-966
27. Deakin JFW, Pennell I, Upadhyaya AJ, et al. A neuroendocrine study of 5-HT function in depression: evidence for psychosocial causation. Psychopharmacology (Berl) 1990;101:85-92
28. Siever LS, Murphy DL, Slater S, et al. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 1983;34:1029-1039
29. O'Keane V, Dinan TG. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence of a diminished responsivity of central serotonergic function. Am J Psychiatry 1991;148:1009-1015
30. O'Keane V, McLoughlin D, Dinan TG. d-Fenfluramine induced prolactin and cortisol release in major depression. J Affect Disord 1992;26:143-150
31. Sachar EJ, Hellman L, Rosswarg HP, et al. Disrupted 24 hour cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973;28:19-24
32. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-1233
33. Holsboer F, Gerken A, Stalla GK, et al. ACTH cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry 1985;20:276-286
34. Gold P, Kling MA, Demitrack MA, et al. Clinical studies with corticotropin-releasing hormone: implications for hypothalamic-pituitary-adrenal dysfunction in depression and related disorders. In: Genten D, Pfaff D, eds. Current Trends in Neuroendocrinology. Berlin, Germany: Springer-Verlag; 1988:238-256
35. Nemeroff CB, Widerlov E, Bissette G, et al. Elevated levels of cerebrospinal fluid CRF-like immunoreactivity in depressed patients. Science 1984; 226:1342-1344
36. DeBellis MD, Chrousos GP, Dorn LD, et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab 1994;78:2449-2455
37. Paykel ES, Myers JK, Dienelt MN. Life events and depression. Arch Gen Psychiatry 1969;21:735-741
38. McEwen BS, Davis PG, Parsons B. The brain as a target for steroid hormone action. Annu Rev Neurosci 1979;2:65-112
39. DeKloet ER, Reul JMH. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987;12:83-105
40. Dinan TG, Barry S. Response of growth hormone to desipramine in endogenous and non-endogenous depression. Br J Psychiatry 1990;156:680-684
41. Thakore JH, Dinan TG. Cortisol synthesis inhibition: a treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 1995;37:364-368
42. Dinan TG. Glucocorticoids and the genesis of depressive illness: a psychobiological model. Br J Psychiatry 1994;164:365-371
43. Dinan TG. Monoamines and steroids: a unifying hypothesis of mood disorder. J Serotonin Res 1995;1:233-243